Phase 3 Readout~month

Phase 3 Topline: A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of A

Indication
Pancreatic Cancer; Metastatic Pancreatic Cancer; Metastatic Pancreatic Adenocarcinoma

Other upcoming events for TNGX

Patent ExpiryPatent/Exclusivity Expiry: KHAPZORY
Patent ExpiryPatent/Exclusivity Expiry: VYKOURA

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of A — TNGX Phase 3 Readout | BioSniper